(News Bulletin 247) – Icade announced last night the forthcoming sale of its entire stake in Icade Santé (58.3% owned to date by Icade).
‘ The operation is relatively complex and carried out in two stages, but it is globally in line with the scenario developed in our study which concludes with a positive operation for the share price in the short term, but leaves Icade in the lead in the medium term. of a less diversified and clearly less attractive portfolio’ indicates the analysis office.
Invest Securities maintains its target price (57.2E) and its recommendation to buy.
Copyright (c) 2023 News Bulletin 247. All rights reserved.
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
